Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

NCT03097328 is registered in ClinicalTrials.gov with Bradley A. McGregor, MD as lead sponsor.

NCT NCT03097328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03097328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Lead sponsor
Bradley A. McGregor, MD
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2017
Completion date
April 24, 2024
Enrollment
39 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma